JPS5297947A - Prostaglandin-like compounds and method of making same - Google Patents

Prostaglandin-like compounds and method of making same

Info

Publication number
JPS5297947A
JPS5297947A JP1255377A JP1255377A JPS5297947A JP S5297947 A JPS5297947 A JP S5297947A JP 1255377 A JP1255377 A JP 1255377A JP 1255377 A JP1255377 A JP 1255377A JP S5297947 A JPS5297947 A JP S5297947A
Authority
JP
Japan
Prior art keywords
compounds
prostaglandin
making same
vinylene
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1255377A
Other languages
English (en)
Inventor
Masaki Hayashi
Seiji Kori
Haniroku Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of JPS5297947A publication Critical patent/JPS5297947A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP1255377A 1976-02-10 1977-02-09 Prostaglandin-like compounds and method of making same Pending JPS5297947A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5145/76A GB1520942A (en) 1976-02-10 1976-02-10 Postaglandin analogues

Publications (1)

Publication Number Publication Date
JPS5297947A true JPS5297947A (en) 1977-08-17

Family

ID=9790556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1255377A Pending JPS5297947A (en) 1976-02-10 1977-02-09 Prostaglandin-like compounds and method of making same

Country Status (5)

Country Link
US (1) US4110341A (ja)
JP (1) JPS5297947A (ja)
DE (1) DE2705164A1 (ja)
FR (1) FR2340931A1 (ja)
GB (1) GB1520942A (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514383A (en) * 1967-06-26 1970-05-26 Upjohn Co Process for preparing prostaglandins and analogs thereof
US3845042A (en) * 1972-08-21 1974-10-29 American Home Prod 11-substituted-prostaglandin derivatives
US3931296A (en) * 1972-12-29 1976-01-06 Masaki Hayashi Trans-Δ2 -prostaglandins
US3950363A (en) * 1975-03-10 1976-04-13 The Upjohn Company Prostaglandin cyclic ethers

Also Published As

Publication number Publication date
GB1520942A (en) 1978-08-09
US4110341A (en) 1978-08-29
DE2705164A1 (de) 1977-08-11
FR2340931B1 (ja) 1980-11-21
FR2340931A1 (fr) 1977-09-09

Similar Documents

Publication Publication Date Title
JPS5278848A (en) Preparation of novel propionic acid ester derivatives
JPS5395958A (en) Prostaglandin analogues and process for their preparation
JPS5297947A (en) Prostaglandin-like compounds and method of making same
JPS5368753A (en) Thiaprostanoic acid derivatives and their preparation
JPS5419946A (en) Prostaglandin analog compound and their preparation
JPS5221392A (en) Process for preparing prostaglandin derivatives
JPS5236646A (en) Process for preparation of prostaglandin derivatives and pharmceutical composition containing the compounds as effectual components
JPS527994A (en) Process for preparing novel pyrimido (4,5-d) pyrimidine derivatives
JPS5325544A (en) Prostaglandin-like compounds, their preparation and pharmaceutical compositions containing the same as active ingredients
JPS5283524A (en) Novel dicarbonyl compounds
JPS5398953A (en) Prostaglandin x analogues and process for their preparation
JPS51128948A (en) Prostaglandin analogues, process for preparing thereof and pharmaceuti cal compositions containing said analofues
JPS5283714A (en) Novel alkyl ester derivatives of 16-alkyl-20-alkoxyprostadienoic acids
JPS5424883A (en) Prostaglandin analogues and their preparation
JPS51122040A (en) A process for preparing prostaglandin analogues
JPS52118441A (en) 2-carbamoyl-3-methyl-3-(4-isobutylphenyl)glycidic acid derivatives an d method of preparing the same
JPS5373566A (en) 7,8,9,10,-tetrahydrophenanthridone-3-acetic acids
JPS5297943A (en) Prostaglandin derivatives
JPS51125046A (en) Process for preparing prostaglandin analogues
JPS5262295A (en) Preparation of n1-oxy-2-thioadenosines
JPS51141863A (en) Process for preparing organo-phosphoric acid esters
JPS5297946A (en) Prostaglandin derivatives and broncho-dilators containing same
JPS5371078A (en) Phenanthridine-3-acetic acids.
JPS5293749A (en) Preparation of beta-dihalogenoethenyl-cyclopropane derivatives
JPS51128942A (en) Prostaglandin analogues, process for preparing there of and pharmaceut ical compositions containing said analogues